I’m 29, and I’m about to buy my first home. My plan is to buy a duplex, and rent out the other side to help pay down the mortgage quickly. A good friend, who is like a brother to me, wants to be my ...

Kirsten Dunst, buoyed by the success of 'A Minecraft Movie,' has expressed her desire to join its potential sequel. She aims for a project that resonates with her children and proves financially ...

This transcript was created using speech recognition software. While it has been reviewed by human transcribers, it may contain errors. Please review the episode audio before quoting from this ...

DEAR ERIC: My sister-in-law is ill and not expected to live much longer. My brother has already commented that he is looking forward to traveling with my wife and me after she passes since we have ...

If your laptop’s small screen is starting to feel cramped, it might be time to put your big TV to better use. Connecting your computer to your television can give you a more comfortable way to browse ...

Sareena was a senior editor for CNET covering the mobile beat, including device reviews. She is a seasoned multimedia journalist with more than a decade's worth of experience producing stories for ...

You wouldn't think Poison and U2 would have much in common, but guess what? They are the only two major classic rock bands who are currently using their most famous lineups. Apart from a five-year ...

If you want to support independent women's media, become a Mamamia subscriber. Get an all-access pass to everything we make, including exclusive podcasts, articles, videos and our exercise app, MOVE.

Each airline has its own restrictions for how large your carry-on luggage can be. Many or all of the products on this page are from partners who compensate us when you click to or take an action on ...

We've all seen it happen: finding the motivation to actually make it to 6 a.m. boot-camp with a friend; nailing the last round of squats when you see those around you powering through; or pushing ...

Merck’s MRK strong foothold in the oncology space is propelled by its biggest revenue driver, Keytruda. The blockbuster PD-L1 inhibitor alone accounted for more than 50% of the company’s ...